Related Experiment Videos
Adult polyglucosan body disease: a postmortem correlation study
E Sindern1, F Ziemssen, T Ziemssen
1Department of Neurology, BG-Kliniken Bergmannsheil, Ruhr University, Bochum, Germany. eckhart.sindern@ruhr-uni-bochum.de
Neurology
|July 23, 2003
Summary
Adult polyglucosan body disease, caused by glycogen branching enzyme gene mutations, leads to polyglucosan body accumulation in organs. This study confirms no tissue-specific GBE isoforms exist.
Area of Science:
- Biochemistry
- Genetics
- Neuropathology
Background:
- Adult polyglucosan body disease (APBD) is a rare genetic disorder.
- It is characterized by the accumulation of abnormal storage material called polyglucosan bodies.
- Mutations in the glycogen branching enzyme (GBE) gene are implicated in APBD pathogenesis.
Observation:
- Autopsy of a 50-year-old female APBD patient revealed polyglucosan bodies in the heart, brain, and nerves.
- Glycogen branching enzyme (GBE) activity was reduced in affected tissues (heart, brain, nerve).
- GBE activity was normal in unaffected tissues.
Findings:
- Missense mutations (Arg515His, Arg524Gln) were identified in the GBE gene.
- GBE mRNA transcript levels were consistent across all tissues examined, including unaffected ones.
- This suggests a lack of tissue-specific GBE isoforms contributing to the disease.
Implications:
- The findings support the hypothesis that APBD results from a generalized GBE deficiency rather than a tissue-specific defect.
- Understanding GBE's role is crucial for developing targeted therapies for APBD.
- This study provides insights into the molecular mechanisms underlying polyglucosan storage diseases.